Investors
entX Limited is an Australian nuclear science and engineering company developing scalable technologies across healthcare, space and defence. The Group is focused on medical isotope production and robust radiopharmaceutical supply chains, alongside innovative radiation-based power systems including GenX and Radioisotope Heating Units (RHUs).
These activities are underpinned by platform technologies, intellectual property, specialist capabilities, research and industry partnerships. Together, they position entX to address growing global demand for critical healthcare inputs and advanced technologies, while building sovereign Australian capability and progressing opportunities towards commercialisation.
We advance technology to transform lives and deliver lasting environmental, social, and economic benefits.
NEW Investor Webinar from Bryn Jones
In this webinar, Managing Director Bryn Jones provides a comprehensive overview of entX’s strategy, highlighting how our core capabilities in radioisotope sourcing, processing and purification underpin three high-growth sectors: healthcare, space & defence.
Watch the full update.
Fuel Innovation, Drive Impact, Unlock Growth
Being an investor with entX means backing groundbreaking technologies that address global challenges in.
Join us to drive innovation, create lasting impact, and unlock substantial growth opportunities in the pursuit of a bright future.
The Entx Advantage
Proven capability of developing complex chemical processes
Improving on existing technologies
Developing new revenue sources
For enquiries relating to shareholdings, please contact our registry:
Computershare Investor Services Pty Ltd
GPO Box 2975
Melbourne Victoria 3001